About the Authors

Amanda Mocroft

a.mocroft@ucl.ac.uk

Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

Jens D. Lundgren

Affiliations Copenhagen HIV programme, University of Copenhagen, Copenhagen, Denmark, Department of Infectious Diseases, Copenhagen University Hospital/Rigshospitalet, Copenhagen, Denmark

Miriam Lewis Sabin

Affiliation Copenhagen HIV programme, University of Copenhagen, Copenhagen, Denmark

Antonella d'Arminio Monforte

Affiliation Department of Health Sciences, Institute of Infectious Diseases, Milan, Italy

Norbert Brockmeyer

Affiliation Department of Dermatology, Venerology, and Allergology, St. Josef Hospital, Ruhr-Universität Bochum, Bochum, Germany

Jordi Casabona

Affiliation CEEISCAT (Agència de Salut Pública de Catalunya) and CIBERESP, Badalona, Catalonia, Spain

Antonella Castagna

Affiliation Department of Infectious Diseases IRCCS San Raffaele, Milan, Italy

Dominique Costagliola

Affiliations UPMC Université Paris 06, UMR_S 943, Paris, France, INSERM, UMR_S 943, Paris, France

Francois Dabis

Affiliations Université of Bordeaux, ISPED, Centre Inserm, U897–Epidémiologie–Biostatistiques, Bordeaux, France, Inserm U897–Epidémiologie–Biostatistiques, Bordeaux, France

Stéphane De Wit

Affiliation Saint-Pierre Hospital, Brussels, Belgium

Gerd Fätkenheuer

Affiliation Universität Köln, Cologne, Germany

Hansjakob Furrer

Affiliation Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland

Anne M. Johnson

Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

Marios K. Lazanas

Affiliation 3rd Internal Medicine Department and Infectious Disease Unit, Red Cross General Hospital of Athens, Greece

Catherine Leport

Affiliations Université Paris Diderot, Sorbonne Paris Cité, UMR 738, Paris, France, INSERM, UMR 738, Paris, France

Santiago Moreno

Affiliation Department of Infectious Diseases. University Hospital Ramón y Cajal, IRYCIS, Madrid, Spain

Niels Obel

Affiliation Department of Infectious Diseases, Copenhagen University Hospital/Rigshospitalet, Copenhagen, Denmark

Frank A. Post

Affiliation Kings College London School of Medicine, London, United Kingdom

Joanne Reekie

Affiliations Department of Infection and Population Health, University College London, London, United Kingdom, The Kirby Institute, University of New South Wales, Sydney, Australia

Peter Reiss

Affiliations Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, The Netherlands, Stichting HIV Monitoring, Amsterdam, The Netherlands

Caroline Sabin

Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

Adriane Skaletz-Rorowski

Affiliation German Competence Network for HIV/AIDS, St. Josef Hospital, Ruhr-Universität Bochum, Bochum, Germany

Ignacio Suarez-Lozano

Affiliation Infectious Diseases Unit, Complejo Hospitalario de Huelva, Spanish VACH Cohort, Spain

Carlo Torti

Affiliations University Division of Infectious and Tropical Diseases, University and Spedali Civili of Brescia, Brescia, Italy, Department of Medical and Surgical Sciences, Unit of Infectious Diseases, University “Magna Graecia,” Catanzaro, Italy

Josiane Warszawski

Affiliation INSERM CESP U1018, Université Paris-Sud, AP-HP Public Health Department, Le Kremlin-Bicêtre, France

Robert Zangerle

Affiliation Medical University Innsbruck, Innsbruck, Austria

Céline Fabre-Colin

Affiliations Université de Bordeaux, ISPED, Centre INSERM U897-Epidémiologie Statistique, Bordeaux, France, INSERM, ISPED, Centre INSERM U897-Epidémiologie Statistique, Bordeaux, France

Jesper Kjaer

Affiliation Copenhagen HIV programme, University of Copenhagen, Copenhagen, Denmark

Genevieve Chene

Affiliations Université de Bordeaux, ISPED, Centre INSERM U897-Epidémiologie Statistique, Bordeaux, France, INSERM, ISPED, Centre INSERM U897-Epidémiologie Statistique, Bordeaux, France

Jesper Grarup

Affiliation Copenhagen HIV programme, University of Copenhagen, Copenhagen, Denmark

Ole Kirk

Membership of the Late Presenters Working Group and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study is provided in the Acknowledgments.

Affiliations Copenhagen HIV programme, University of Copenhagen, Copenhagen, Denmark, Department of Infectious Diseases, Copenhagen University Hospital/Rigshospitalet, Copenhagen, Denmark

Competing Interests

AM has received lecture fees, honoraria, and/or consultancies from Pfizer, BI, BMS, Merck, and Gilead. Ad'A is an advisory board member of BMS, Jannsen, Gilead, and ViiV. GF has received honoraria for lectures and advisory boards from Abbott, Bristol-Myers Squibb, Gilead, Janssen-Cilag, and Merck Sharp & Dohme. Research grant to GF from the German Federal Ministry of Education and Research (BMBF) 01KI1017. AJ is a Governor of the Wellcome Trust, a charitable research funding body; in 2011 was a specialist adviser to House of Lords Select Committee on HIV/AIDS; is a member of the UK Expert Advisory Group on AIDS; receives research grant funding from the UK Medical Research Council, Wellcome Trust, UK National Institute for Health Research, and Department of Health. CL has received these research grants: ANRS CMIT soutien (Aproco-Copilote ANRS CO08 HIV cohort, 1997–2012); IMMI (Cohort Fluco A(H1N1) pandemic influenza, 2009–2012); Ministère de la Santé PHRC (Bivir influenza trial, Oseltamivir Zanamivir, 2006–2012). CS has received funding for Advisory Board membership, speaker panels, and provision of educational materials for Gilead Sciences, Abbott Pharmaceuticals, ViiV, Merck Sharp & Dohme, Janssen-Cilag, and Bristol-Myers Squibb. CT has received honoraria to act as speaker at CME conferences on antiretroviral therapy and HIV disease management from several companies producing antiretroviral drugs, received travel grants to participate in scientific conferences, and acted as scientific consultant for the same companies. GC has had scientific responsibilities in projects receiving specific grant support from the French Agency for Research on AIDS and Viral Hepatitis (ANRS), the European Commission (Framework Program 7), UK Medical Research Council, US National Institute of Health (NIH), Fondation Plan Alzheimer, Gilead, Tibotec, Boehringer Ingelheim, GlaxoSmithKline, Roche, Pfizer, Merck, Abbott, Bristol-Myers Squibb, Janssen, ViiV Healthcare – these grants are managed through her Institution or a non-profit society. GC also serves as Academic Editor on PLOS ONE and is on the editorial board of the BMC Infectious Diseases Journal. OK has received honoraria, consultancy, lecture fees, and travel grants from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme, Roche, and ViiV Healthcare, and has served/is serving on Advisory Boards for Gilead Sciences, Merck Sharp & Dohme, and ViiV Healthcare. No other competing interests have been declared.

Author Contributions

Conceived and designed the experiments: AM JL MS Ad'A NB JC AC DC FD SDW GF HF AJ ML CL SM NO FP JR PR CS ASR ISL CT JW RZ CFC JK GC JG OK. Analyzed the data: AM JR. Wrote the first draft of the manuscript: AM. Contributed to the writing of the manuscript: AM JL MS Ad'A NB JC AC DC FD SDW GF HF AJ ML CL SM NO FP JR PR CS ASR ISL CT JW RZ CFC JK GC JG OK. ICMJE criteria for authorship read and met: AM JL MS Ad'A NB JC AC DC FD SDW GF HF AJ ML CL SM NO FP JR PR CS ASR ISL CT JW RZ CFC JK GC JG OK. Agree with manuscript results and conclusions: AM JL MS Ad'A NB JC AC DC FD SDW GF HF AJ ML CL SM NO FP JR PR CS ASR ISL CT JW RZ CFC JK GC JG OK. Enrolled patients: AM JL MS Ad'A NB JC AC DC FD SDW GF HF AJ ML CL SM NO FP JR PR CS ASR ISL CT JW RZ CFC JK GC JG OK.